Back to Psychiatry
PsychiatryvModified (2015)Evidence-Based

Modified Minnesota Detoxification Scale (mMINDS)

Scores symptoms for patients with alcohol withdrawal syndrome, particularly useful in critically ill patients and ICU settings

Clinical Input Parameters

bpm
Range: 40 — 200 bpm
mmHg
Range: 40 — 150 mmHg
Clinical Assessment
Awaiting Parameters
mminds score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Modified Minnesota Detoxification Scale (mMINDS) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within psychiatry.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Sum of points from all 9 parameters: Pulse (0-2), DBP (0-2), Tremor (0-6), Sweat (0-6), Hallucinations (0-3), Agitation (0-9), Orientation (0-6), Delusions (0-6), Seizures (0-6). Range: 0-46 points.

Clinical Pearls & Practice Notes

  • Specifically designed for use in critically ill patients and ICU settings
  • Preferred over CIWA-Ar in patients who cannot provide subjective responses
  • If unable to assess a parameter due to over-sedation or mechanical ventilation, score = 0
  • Validated primarily in medical and surgical intensive care units
  • Associated with shorter ICU stays and reduced benzodiazepine use compared to CIWA-Ar
  • Helps guide symptom-triggered benzodiazepine therapy protocols
  • More objective assessment compared to subjective scales like CIWA-Ar
  • Scores ≥21 indicate moderate to severe withdrawal requiring aggressive treatment
  • Consider ICU monitoring for progressive increases in score or scores >20
  • Useful for monitoring treatment response and titrating benzodiazepine therapy

Evidence & Literature Citations

  1. Hack JB, Hoffmann RS, Nelson LS. Resistant alcohol withdrawal: does an unexpectedly large sedative requirement identify these patients early? J Med Toxicol. 2006 Jun;2(2):55-60. doi: 10.1007/BF03161175.
  2. Awissi DK, Lebrun G, Fagnan M, Skrobik Y. Alcohol, nicotine, and iatrogenic withdrawals in the ICU. Crit Care Med. 2013 Sep;41(9 Suppl 1):S57-68. doi: 10.1097/CCM.0b013e3182a168d5.
  3. DeCarolis DD, Rice KL, Ho L, Willenbring ML, Cassaro S. Symptom-driven lorazepam protocol for treatment of severe alcohol withdrawal delirium in the intensive care unit. Pharmacotherapy. 2007 Apr;27(4):510-8. doi: 10.1592/phco.27.4.510.
  4. Foy A, March S, Drinkwater V. Use of an objective clinical scale in the assessment and management of alcohol withdrawal in a large general hospital. Alcohol Clin Exp Res. 1988 Jun;12(3):360-4. doi: 10.1111/j.1530-0277.1988.tb00208.x.

Score Interpretation Ranges

Minimal Withdrawal0 – 10 pts

Minimal to no withdrawal symptoms

Mild Withdrawal11 – 20 pts

Mild withdrawal symptoms

Moderate Withdrawal21 – 30 pts

Moderate withdrawal symptoms

Severe Withdrawal31 – 46 pts

Severe withdrawal symptoms

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.